Hyperinsulinaemia and Alzheimer's disease.

Hyperinsulinaemia and Alzheimer's disease.

Because the aetiology of Alzheimer's disease (AD) remains unclear, and fasting hyperinsulinaemia has been incriminated in several human diseases, we examined the relationship between AD, fasting plasma insulin, glucose, body mass index and waist: hip ratio in 24 men and 24 women aged 58-90 year...

Полное описание

Библиографические подробности
Главные авторы:	Razay, G, Wilcock, G
Формат:	Journal article
Язык:	English
Опубликовано:	1994

Схожие документы

Galantamine in Alzheimer's disease.
по: Razay, G, и др.
Опубликовано: (2008)

The metabolic syndrome and Alzheimer disease.
по: Razay, G, и др.
Опубликовано: (2007)

Obesity, abdominal obesity and Alzheimer disease.
по: Razay, G, и др.
Опубликовано: (2006)

Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case-control study
по: Razay, G, и др.
Опубликовано: (2011)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
по: Wilcock, G, и др.
Опубликовано: (1993)

Determining a diagnostic algorithm for hyperinsulinaemia
по: Catherine A.P. Crofts, и др.
Опубликовано: (2019-06-01)

Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
по: Razay, G, и др.
Опубликовано: (2009)

Hyperinsulinaemia in pregnancy and gestational outcomes: A case series
по: Sylvia M. North, и др.
Опубликовано: (2022-07-01)

Insights from engraftable immunodeficient mouse models of hyperinsulinaemia
по: Michelle L. Maugham, и др.
Опубликовано: (2017-03-01)

Severe Diltiazem Poisoning Treated with Hyperinsulinaemia-Euglycaemia and Lipid Emulsion
по: Nadine Monteiro, и др.
Опубликовано: (2013-01-01)

Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
по: Leanne Hodson, и др.
Опубликовано: (2019-10-01)

Hyperinsulinaemia down-regulates TLR4 expression in the mammalian heart
по: Melody ede Laat, и др.
Опубликовано: (2014-07-01)

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?
по: Lynda Guildford, и др.
Опубликовано: (2020-05-01)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
по: Arturo Hernández-Yero, и др.
Опубликовано: (2012-01-01)

Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas
по: Isabella D. Cooper, и др.
Опубликовано: (2021-09-01)

Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
по: J. Bashir, и др.
Опубликовано: (2022-06-01)

Correlation of serum homocysteine levels and hyperinsulinaemia with body mass index in polycystic ovarian syndrome
по: Rashmi Bhushan, и др.
Опубликовано: (2022-01-01)

Body iron status and association with hyperinsulinaemia and hyperandrogenism in non-obese Indian women with polycystic ovarian syndrome
по: P. Supriya, и др.
Опубликовано: (2012-01-01)

Treatment for Alzheimer's disease.
по: Wilcock, G
Опубликовано: (2000)

Neurotrophins in Alzheimer's disease
по: Wilcock, G
Опубликовано: (2002)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
по: Wilcock, G
Опубликовано: (1990)

Alzheimer's disease--current issues.
по: Wilcock, G
Опубликовано: (1988)

Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis
по: Martin Sillence, и др.
Опубликовано: (2022-01-01)

Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses.
по: Samira Rahnama, и др.
Опубликовано: (2020-01-01)

Endothelial cell apoptosis in brown adipose tissue of rats induced by hyperinsulinaemia: the possible role of TNF-α
по: M. Markelic, и др.
Опубликовано: (2011-11-01)

Hypothyroidism in utero stimulates pancreatic beta cell proliferation and hyperinsulinaemia in the ovine fetus during late gestation
по: Harris, S, и др.
Опубликовано: (2017)

Treatment of the cholinergic impairment in Alzheimer's disease
по: Wilcock, G
Опубликовано: (1994)

Age and Alzheimer's disease.
по: Wilcock, G, и др.
Опубликовано: (1983)

Treating Alzheimer's disease.
по: Wilcock, G, и др.
Опубликовано: (1995)

Velnacrine for Alzheimer's disease.
по: Birks, J, и др.
Опубликовано: (2004)

Current approaches to the treatment of Alzheimer's disease.
по: Wilcock, G
Опубликовано: (1996)

Bapineuzumab in Alzheimer's disease: where now?
по: Wilcock, G
Опубликовано: (2010)

Effectiveness of SMS 201-995, a synthetic, long-acting somatostatin analogue, in treatment of quinine-induced hyperinsulinaemia.
по: Phillips, R, и др.
Опубликовано: (1986)

Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
по: Erika Harno, и др.
Опубликовано: (2021-07-01)

THE ROLE OF GROWTH-FACTORS AND NEUROPEPTIDES IN ALZHEIMERS-DISEASE
по: Wilcock, G
Опубликовано: (1994)

Asymmetry of pathology in Alzheimer's disease.
по: Wilcock, G, и др.
Опубликовано: (1987)

The olfactory bulbs in Alzheimer's disease.
по: Esiri, M, и др.
Опубликовано: (1984)

The increasing burden of Alzheimer disease.
по: Sadik, K, и др.
Опубликовано: (2003)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
по: Wilcock, G
Опубликовано: (1994)

The challenge of Alzheimer's disease--no longer a silent epidemic.
по: Wilcock, G
Опубликовано: (1988)